Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - NHS Quality Improvement Scotland makes appointment:

This article was originally published in Clinica

Executive Summary

Professor Sir Graham Teasdale has been appointed to chair the board of NHS Quality Improvement Scotland for a four-year term. Professor Teasdale has over 25 years of "frontline experience" in the NHS and is, among other things, president of the Royal College of Physicians and Surgeons of Glasgow. NHS-QIS is the counterpart of the National Institute for Health and Clinical Excellence (for the NHS in England and Wales); while it often provides technology usage policy based on NICE decisions, NHS-QIS has also led on key technology areas, such as B-type natriuretic peptide (BNP) testing for cardiac failure, issued in May 2005 (see Clinica No 1156, p 8).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel